University of Minnesota presents new SARS-CoV-2 NSP14 methyltransferase inhibitors
Dec. 21, 2023
University of Minnesota has divulged nonstructural protein 14 (NSP14) (SARS-CoV-2) inhibitors reported to be useful for the treatment of SARS-CoV-2 infection.
